Delcath Systems Inc. [NASDAQ: DCTH] gained 23.27% or 2.85 points to close at $15.10 with a heavy trading volume of 1307676 shares. The company report on March 31, 2021 that Delcath Systems, Inc. Shares Additional Information Regarding FOCUS Trial Power Calculation.
20.1% Lower Bound of Preliminary ORR Analysis Exceeds Required 8.3% Threshold.
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, provided additional information regarding the power calculation for the Phase 3 FOCUS trial of HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) in patients with liver dominant metastatic ocular melanoma (mOM).
It opened the trading session at $13.19, the shares rose to $15.19 and dropped to $12.23, the range by which the price of stock traded the whole day. The daily chart for DCTH points out that the company has recorded 29.39% gains over the past six months. However, it is still -149.17% lower than its most recent low trading price.
If we look at the average trading volume of 258.51K shares, DCTH reached to a volume of 1307676 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Delcath Systems Inc. [DCTH]:
Canaccord Genuity have made an estimate for Delcath Systems Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 09, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on January 05, 2021, representing the official price target for Delcath Systems Inc. stock. Previously, the target price had yet another raise to $19, while Laidlaw analysts kept a Buy rating on DCTH stock.
The Average True Range (ATR) for Delcath Systems Inc. is set at 1.76, with the Price to Sales ratio for DCTH stock in the period of the last 12 months amounting to 56.23. The Price to Book ratio for the last quarter was 19.87, with the Price to Cash per share for the same quarter was set at 1.72.
Trading performance analysis for DCTH stock
Delcath Systems Inc. [DCTH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.60. With this latest performance, DCTH shares dropped by -12.57% in over the last four-week period, additionally plugging by 29.39% over the last 6 months – not to mention a rise of 58.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DCTH stock in for the last two-week period is set at 41.82, with the RSI for the last a single of trading hit 42.00, and the three-weeks RSI is set at 43.09 for Delcath Systems Inc. [DCTH]. The present Moving Average for the last 50 days of trading for this stock 18.58, while it was recorded at 14.42 for the last single week of trading, and 14.11 for the last 200 days.
Delcath Systems Inc. [DCTH]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Delcath Systems Inc. [DCTH] shares currently have an operating margin of -1294.23 and a Gross Margin at +49.45. Delcath Systems Inc.’s Net Margin is presently recorded at -1467.56.
Return on Total Capital for DCTH is now -197.92, given the latest momentum, and Return on Invested Capital for the company is -263.02. Return on Equity for this stock declined to -307.31, with Return on Assets sitting at -98.90. When it comes to the capital structure of this company, Delcath Systems Inc. [DCTH] has a Total Debt to Total Equity ratio set at 13.34. Additionally, DCTH Total Debt to Total Capital is recorded at 11.77, with Total Debt to Total Assets ending up at 8.50. Long-Term Debt to Equity for the company is recorded at 2.04, with the Long-Term Debt to Total Capital now at 1.80.
Reflecting on the efficiency of the workforce at the company, Delcath Systems Inc. [DCTH] managed to generate an average of -$671,000 per employee. Receivables Turnover for the company is 30.20 with a Total Asset Turnover recorded at a value of 0.07.Delcath Systems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.30.
Delcath Systems Inc. [DCTH]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DCTH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Delcath Systems Inc. go to 15.00%.
An analysis of insider ownership at Delcath Systems Inc. [DCTH]
There are presently around $30 million, or 38.80% of DCTH stock, in the hands of institutional investors. The top three institutional holders of DCTH stocks are: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with ownership of 500,000, which is approximately New of the company’s market cap and around 0.40% of the total institutional ownership; SILVERARC CAPITAL MANAGEMENT, LLC, holding 351,616 shares of the stock with an approximate value of $5.31 million in DCTH stocks shares; and VANGUARD GROUP INC, currently with $3.74 million in DCTH stock with ownership of nearly New of the company’s market capitalization.
Positions in Delcath Systems Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 18 institutional holders increased their position in Delcath Systems Inc. [NASDAQ:DCTH] by around 1,903,959 shares. Additionally, 7 investors decreased positions by around 59,219 shares, while 5 investors held positions by with 52,438 shares. The mentioned changes placed institutional holdings at 2,015,616 shares, according to the latest SEC report filing. DCTH stock had 16 new institutional investments in for a total of 1,885,246 shares, while 2 institutional investors sold positions of 43,339 shares during the same period.